- •Contents
- •Contributors
- •Preface
- •Glossary
- •2. Synthesising the evidence
- •3. Evidence in practice
- •4. Allergic conjunctivitis
- •6. Viral conjunctivitis
- •7. Screening older people for impaired vision
- •8. Congenital and infantile cataract
- •9. Congenital glaucoma
- •13. Infantile esotropia
- •14. Accommodative esotropia
- •15. Childhood exotropia
- •17. Entropion and ectropion
- •18. Thyroid eye disease
- •19. Lacrimal obstruction
- •20. Trachoma
- •21. Corneal abrasion and recurrent erosion
- •22. Herpes simplex keratitis
- •23. Suppurative keratitis
- •24. Ocular toxoplasmosis
- •25. Onchocerciasis
- •27. Cytomegalovirus retinitis in patients with AIDS
- •28. Anterior uveitis
- •29. Primary open angle glaucoma and ocular hypertension
- •30. Acute and chronic angle closure glaucoma
- •31. Modification of wound healing in glaucoma drainage surgery
- •32. Cataract surgical techniques
- •33. Intraocular lens implant biocompatibility
- •34. Multifocal and monofocal intraocular lenses
- •35. Perioperative management of cataract surgery
- •36. Age-related macular degeneration
- •37. Treatment of lattice degeneration and asymptomatic retinal breaks to prevent rhegmatogenous retinal detachment
- •38. Surgery for proliferative vitreoretinopathy
- •39. Rhegmatogenous retinal detachment
- •40. Surgical management of full-thickness macular hole
- •41. Retinal vein occlusion
- •42. Medical interventions for diabetic retinopathy
- •43. Photocoagulation for sight threatening diabetic retinopathy
- •44. Vitrectomy for diabetic retinopathy
- •45. Optic neuritis
- •47. Idiopathic intracranial hypertension
- •48. Toxic and nutritional optic neuropathies
- •49. Traumatic optic neuropathy
- •50. Ocular adnexal and orbital tumours
- •51. Uveal melanoma
- •52. Retinoblastoma
- •Index
34 Multifocal and monofocal intraocular lenses
Martin Leyland
Background
Current techniques of cataract surgery and IOL implantation allow accurate prediction of postoperative refraction such that there can now be a reasonable expectation of good uncorrected distance acuity. This has been driven partly by the change from cataract surgery using a large (10 mm) incision to small (3–4 mm) incision phacoemulsification surgery. Among other benefits, this change offers greater predictability of refractive outcomes, which is a necessary pre-requisite for good visual acuity without the need for glasses.1,2
Treatment options
Standard IOLs used have a fixed refractive power, so that the focal length is fixed (monofocal). This means that most patients will require a reading addition to their distance glasses.3 While the majority of people undergoing cataract surgery may be happy to use reading glasses, a proportion are likely to seek good unaided near vision as well as distance vision. The need for reading glasses for near vision is unlikely to be considered an important issue at present in developing countries, where the burden of blindness due to cataract is very high.
One approach to improve near visual acuity is to modify the IOL. An IOL may provide near and distance vision if both powers are present within the optical zone. This has been attempted using diffractive optics or with zones of differing refractive power. Both types of IOL divide light up to focus at two (bifocal) or more (multifocal) points, so that both near and distant objects may be focussed on the retina. Optical evaluation of multifocal IOLs indicates that a twoto threefold increase in the depth of field is achieved at the expense of a 50% reduction in the contrast of the retinal image.4
Question
Does the use of multifocal intraocular lenses offer benefits over the current standard treatment of monofocal intraocular lens implantation?
The evidence
A systematic review of randomised controlled trials of multifocal intraocular lenses was undertaken to determine whether their use offers benefits over the current standard treatment of monofocal intraocular lens implantation.5 Eight RCTs were identified for inclusion in the review,5–12 and the characteristics of these trials are summarised in Table 34.1.
Question
Does the use of multifocal intraocular lenses offer benefits over monofocal intraocular lenses for visual acuity (unaided and corrected)?
The evidence
Distance acuity was described in five trials as the proportion of participants achieving specified acuity levels (Figure 34.1). The proportion of participants achieving less than 6/6 unaided was not significantly different between multifocal and monofocal groups (Peto odds ratio 1·21, 95% CI 0·75−1·96). Three trials describe mean acuity rather than proportions (Figure 34.2). There was no evidence of any difference in acuity between multifocal and monofocal groups (standardised mean difference −0·03, 95% CI −0·24 −0·18).
Similarly, there was no difference between IOL types with respect to the proportion of participants achieving less than 6/6 best corrected visual acuity in seven studies (Peto odds ratio 1·43, 95% CI 0·99–2·09, Figure 34.3). There was no difference in mean best-corrected acuity in the three refractive IOL trials that reported this outcome
(standardised mean difference 0·19, 95% CI −0·03–0·40, Figure 34.4).
Because of significant heterogeneity no meta-analysis was conducted on the data for near visual acuity. The six trials that reported this outcome found that near vision tended to improve with the use of a multifocal IOL (Figure 34.5).
259
|
Outcomes |
Distanceacuity |
|
Intervention |
RigidPMMAIOLs:3Mdiffractive |
monofocalintraocularlenses |
Participants |
SaudiArabia |
comparingmultifocalto |
Methodquality* |
Jadadscore3 |
Characteristicsoftrials |
Method |
Randomised |
Table34.1 |
Trial |
El-Maghraby |
Nearacuity |
|
|
|
|
Distanceacuity |
IOL(815LE)or3Mmonofocal |
IOL(15LE) |
Phacowithcan-opener |
capsulotomy |
|
RigidPMMAIOLs:Allergan |
47%male |
Meanage57years |
Multifocalgroup:39 |
Monofocalgroup:38 |
Unilateral–felloweye notblind |
USA |
Allocationconcealment |
adequate |
|
|
|
Jadadscore5 |
Singlecentre |
Maskingnotstated |
Studyduration2to4months |
|
|
Randomised |
6 |
|
|
|
|
|
etal.,1992 |
|
|
|
|
Steinert |
Nearacuity |
Depthoffield |
Contrastsensitivity |
Glare |
Spectacleuse |
Non-validatedsubjective assessment |
Distanceacuity |
Nearacuity |
Depthoffield |
Contrastsensitivity |
Spectacleuse |
Non-validatedsubjective |
outcome Adversephenomena |
Distanceacuity |
Nearacuity |
Contrastsensitivity |
Spectacleuse |
Non-validatedsubjective |
assessmentofvisual |
qualityquestionnaire |
Adversephenomena |
Distanceacuity |
Nearacuity |
Contrastsensitivity |
Spectacleuse |
Non-validated |
questionnaire |
Adversephenomena |
refractiveIOL(MPC25NB)or |
AllerganmonofocalIOL |
(PC25NB) |
Phaco,capsulotomytypenot |
specified |
|
RigidPMMAIOLs:Allergan |
refractiveIOL(MPC25)or |
AllerganmonofocalIOL(PC25) |
Myopicastigmatismmonofocal |
group |
ECCEwithcan-opener |
capsulotomy |
RigidPMMAIOLs:3Mdiffractive |
IOL(unspecified)or3M |
monofocalIOL(unspecified) |
ECCE,capsulotomytypenot |
specified |
|
|
|
RigidPMMAIOLs:Pharmacia |
diffractiveIOL(808X)or |
PharmaciamonofocalIOL |
(808D) |
PhacoandECCE |
Capsulotomynotspecified |
|
42%male |
Meanage72years |
Multifocalgroup:32 |
Monofocalgroup:30 |
Unilateral–felloweye |
phakic |
UK |
42%male |
Meanage77years |
Multifocalgroup:25 |
Monofocalgroup:25 |
Unilateral–felloweye |
phakic,mostcataractous |
Italy |
41%male |
Meanage71years |
Multifocalgroup:38 |
Monofocalgroup:42 |
Unilateral–felloweye |
phakicwithnosignificant |
cataract |
Europe |
49%male |
Meanage66years |
Multifocalgroup:79 |
Monofocalgroup:70 |
Unilateral–statusof |
felloweyenotreported |
Allocationconcealment |
adequate |
|
|
|
|
Jadadscore2 |
Allocationconcealment |
unclear |
|
|
|
|
Jadadscore1 |
Allocationconcealment |
unclear |
|
|
|
|
|
Jadadscore1 |
Allocationconcealment |
adequate |
|
|
|
|
Multicentre |
Double-masked |
Studyduration3to6months |
|
|
|
Randomised |
Singlecentre |
Maskingnotstated |
Studyduration4to6months |
|
|
|
Randomised |
Singlecentre |
Maskingnotstated |
Studyduration12months |
|
|
|
|
Randomised |
Multicentre |
Open/unmasked |
Studyduration5to6months |
|
|
|
etal., |
1992 |
|
|
|
|
Percival |
8 |
|
|
|
|
|
Rossetti |
9 |
|
|
|
|
|
|
Allenetal., |
1996 |
|
|
|
|
|
|
|
|
|
etal.,1993 |
|
|
|
|
|
etal.,1994 |
|
|
|
|
|
|
|
|
|
|
|
||||||
|
10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
|
|
|
|
|
(Continued)
Outcomes
Intervention
Method quality* Participants
(Continued) |
Method |
Table34.1 |
Trial |
USA, Germany and Austria Foldable 3-piece silicone optic, Distance acuity
Jadad score 5
Randomised
.,al etJavitt
Nearacuity |
Validatedquestionnaire |
(modifiedcataractTyPE) |
Validatedqualityoflife |
questionnaire |
|
Distanceacuity |
PMMAhapticIOLs:Allergan |
refractiveIOL(SA40N)or |
AllerganmonofocalIOL |
(SI40NB)phacowithcontinuous |
circularcapsulorhexis |
|
DomilensasphericrefractiveIOL |
44%male |
Meanagenotgiven,50% |
65–74years |
Multifocalgroup:124 |
Monofocalgroup:111 |
Bilateralsurgery |
India |
Allocationconcealment |
adequate |
|
|
|
|
Jadadscore1 |
Multi-centre |
Double-masked |
Studyduration3to6months |
|
|
|
Randomised |
2000 |
|
|
|
|
|
Kamlesh |
7 |
|
|
|
|
|
|
(Progress 3) or monofocal IOL Near acuity
Allocation concealment Gender not given
Single centre
.,al et
Depthoffield |
Contrastsensitivity |
Spectacleuse |
Non-validatedsubjective |
outcome |
Adversephenomena |
Distanceacuity |
(Flex65)ECCEwithenvelope |
capsulotomy Refractiveaimnotstated |
|
|
|
Multifocal(refractive,2designs) |
|
Meanage55·7yrs |
(multifocal),53·5yrs |
(monofocal) |
Nonone-cataract |
pathology |
Astigmatismlessthan 1·5dioptres Unilateralsurgery |
UK |
unclear |
Jadadscore5 |
Studyduration3months |
Randomised |
2001 |
Leyland |
14 |
|
Double-masked trial of Allocation concealment Over 50 years of age or monofocal IOL implantation Near acuity
.,al et
Depthoffield |
Contrastsensitivity |
Spectacleuse |
Validatedquestionnaire |
(modifiedcataract |
typeE) |
Adversephenomena |
|
|
Bilateralcataract Surgicalintervention: |
Nonone-cataract Bilateralsmallincisionphacoand |
pathology IOL,aimingforemmetropia |
Lessthan1·5dioptres |
astigmatism |
Bilateralsurgery |
|
with5pointsindicatingthebestmethodology. |
ECCE,extracapsularcataractextraction |
2002 |
intraocularmonofocallenses |
|
|
|
|
|
scoredwasquality*Methodologicalfrom0to5(Jadad,1996) |
lens;intraocularIOL,Abbreviations:PMMA,polymethylmethacrylate; |
|
|
|
|
|
|
|
, |
|
|
|
|
|
|
|
|
13 |
|
adequate |
|
|
|
|
|
|
|
|
bilateralmultifocal,bifocal,or |
|
|
|
|
|
|
|
|
12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Evidence-based Ophthalmology |
|
|
|
|
|
|
|
|
|
Study |
Multifocal |
Monofocal |
|
Peto OR |
|
Weight |
Peto OR |
||
or sub-category |
n/N |
n/N |
|
95% CI |
|
% |
95% CI |
||
01 Refractive IOLs |
|
|
|
|
|
|
|
|
|
Steinert et al., 199210 |
26/32 |
22/30 |
|
|
|
|
|
16·74 |
1·56 (0·48, 5·09) |
Leyland et al., 200212 |
7/45 |
3/16 |
|
|
|
|
|
10·01 |
0·80 (0·17, 3·67) |
Subtotal (95% CI) |
33/77 |
25/46 |
|
|
|
|
|
26·75 |
1·21 (0·48, 3·09) |
Test for heterogeneity: chi square = 0·47, df = 1 (P = 0·49) |
|
|
|
|
|
|
|
||
Test for overall effect: Z = 0·40 (P = 0·69) |
|
|
|
|
|
|
|
|
|
02 Diffractive IOLs |
|
|
|
|
|
|
|
|
|
EI-Magrahby et al., 19926 |
22/28 |
21/33 |
|
|
|
|
|
19·49 |
2·03 (0·68, 6·06) |
Rossetti et al., 19949 |
35/38 |
38/42 |
|
|
|
|
|
9·82 |
1·22 (0·26, 5·72) |
Allen et al., 19965 |
58/79 |
52/70 |
|
|
|
|
|
43·94 |
0·96 (0·46, 1·98) |
Subtotal (95% CI) |
115/145 |
111/145 |
|
|
|
|
|
73·25 |
1·21 (0·69, 2·12) |
Test for heterogeneity: chi square = 1·25, df = 2 (P = 0·53) |
|
|
|
|
|
|
|
||
Test for overall effect: Z = 0·65 (P = 0·51) |
|
|
|
|
|
|
|
|
|
Total (95% CI) |
148/222 |
136/191 |
|
|
|
|
|
100·00 |
1·21 (0·75, 1·96) |
Test for heterogeneity: chi square = 1·72, df = 2 (P = 0·79) |
|
|
|
|
|
|
|
||
Test for overall effect: Z = 0·77 (P = 0·44) |
|
|
|
|
|
|
|
|
|
|
|
0·1 |
0·2 |
0·5 |
1 |
2 |
5 |
10 |
|
|
|
Favours multifocal |
|
Favours monofocal |
|
||||
Figure 34.1 Distance visual acuity – less than 6/6 unaided
Study |
|
Multifocal |
|
Monofocal |
SMD (fixed) |
Weight |
SMD (fixed) |
||||
or sub-category |
N |
Mean (SD) |
N |
Mean (SD) |
|
95% CI |
|
% |
95% CI |
||
|
|
|
|
|
|
|
|
|
|
|
|
01 Refractive IOLs |
|
|
|
|
|
|
|
|
|
|
|
Steinert et al., 199210 |
32 |
−6·33 (1·73) |
30 |
−6·37 (1·93) |
|
|
|
|
|
18·23 |
0·02 (−0·48, 0·52) |
Javitt and Steinert, 20007 |
123 |
−7·78 (1·21) |
109 |
−7·66 (1·36) |
|
|
|
|
|
67·95 |
−0·09 (−0·35, 0·16) |
|
|
|
|
|
|||||||
Leyland et al., 200215 |
45 |
0·08 (0·13) |
16 |
0·05 (0·15) |
|
|
|
|
|
13·83 |
0·22 (−0·35, 0·79) |
Subtotal (95% CI) |
200 |
|
155 |
|
|
|
|
|
|
100·00 |
−0·03 (−0.24, 0·18) |
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|||||
Test for heterogeneity: chi square = 1·00, df = 1 (P = 0·61) |
|
|
|
|
|
|
|
||||
Test for overall effect: Z = 0·27 (P = 0·79) |
|
|
|
|
|
|
|
|
|
||
02 Diffractive IOLs |
|
|
|
|
|
|
|
|
|
|
|
Subtotal (95% CI) |
0 |
|
0 |
|
|
|
|
|
|
|
Not estimable |
Test for heterogeneity: not applicable |
|
|
|
|
|
|
|
|
|
||
Test for overall effect: not applicable |
|
|
|
|
|
|
|
|
|
||
Total (95% CI) |
200 |
|
155 |
|
|
|
|
|
|
100·00 |
−0·03 (−0·24, 0·18) |
|
|
|
|
|
|
|
|||||
Test for heterogeneity: chi square = 1·00, df = 2 (P = 0·61) |
|
|
|
|
|
|
|
||||
Test for overall effect: Z = 0·27 (P = 0·79) |
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
−10 |
−5 |
0 |
|
|
5 |
10 |
|
|
|
|
|
Favours multifocal |
Favours monofocal |
|
|||||
Figure 34.2 Distance visual acuity – mean unaided
Comment
There was no difference between multifocal and monofocal IOL groups with respect to distance visual acuity. Unaided near vision is critical to the assessment of multifocal efficacy, but was reported in a manner that makes comparison between trials difficult. It is not made
clear in most trials whether the reported print size read has been corrected for reading distance so as to allow a near acuity to be calculated. Only two trials explicitly report near acuity.7,13 A further problem is the use of Jaeger cards. These are not standardised between manufacturers, so that J3 from one trial cannot be
262
|
|
|
|
|
|
Multifocal and monofocal intraocular lenses |
|||
Study |
Multifocal |
Monofocal |
|
Peto OR |
|
Weight |
Peto OR |
||
or sub-category |
n/N |
n/N |
|
95% CI |
|
% |
95% CI |
||
01 Refractive IOLs |
|
|
|
|
|
|
|
|
|
Steinert et al., 199210 |
12/32 |
9/30 |
|
|
|
|
|
12·90 |
1·39 (0·49, 3·95) |
Percival and Setty 19938 |
9/25 |
6/25 |
|
|
|
|
|
9·81 |
1·75 (0·53, 5·80) |
Kamlesh et al., 200111 |
1/20 |
5/20 |
|
|
|
|
|
4·79 |
0·22 (0·04, 1·20) |
Leyland et al., 200212 |
4/45 |
2/16 |
|
|
|
|
|
3·90 |
0·67 (0·10, 4·48) |
Subtotal (95% CI) |
26/122 |
22/91 |
|
|
|
|
|
31·39 |
1·03 (0·53, 2·01) |
Test for heterogeneity: chi square = 4·45, df = 3 (P = 0·22) |
|
|
|
|
|
|
|
||
Test for overall effect: Z = 0·08 (P = 0·94) |
|
|
|
|
|
|
|
|
|
02 Diffractive IOLs |
|
|
|
|
|
|
|
|
|
El-Magrahby et al., 19926 |
9/28 |
8/33 |
|
|
|
|
|
11·33 |
1·47 (0·48, 4·48) |
Rossetti et al., 19949 |
18/38 |
19/42 |
|
|
|
|
|
18·39 |
1·09 (0·45, 2·61) |
Allen et al., 19965 |
39/116 |
19/101 |
|
|
|
|
|
38·89 |
2·12 (1·16, 3·87) |
Subtotal (95% CI) |
66/182 |
46/176 |
|
|
|
|
|
68·61 |
1·67 (1·06, 2·63) |
Test for heterogeneity: chi square = 1·58, df = 2 (P = 0·45) |
|
|
|
|
|
|
|
||
Test for overall effect: Z = 2·22 (P = 0·03) |
|
|
|
|
|
|
|
|
|
Total (95% CI) |
92/304 |
68/267 |
|
|
|
|
|
100·00 |
1·43 (0·99, 2·09) |
Test for heterogeneity: chi square = 7·42, df = 6 (P = 0·28) |
|
|
|
|
|
|
|
||
Test for overall effect: Z = 1·89 (P = 0·06) |
|
|
|
|
|
|
|
|
|
|
|
0·1 |
0·2 |
0·5 |
1 |
2 |
5 |
10 |
|
|
|
Favours multifocal |
|
Favours monofocal |
|
||||
Figure 34.3 Distance visual acuity – less than 6/6 best corrected
Study |
|
Multifocal |
|
Monofocal |
SMD (fixed) |
Weight |
SMD (fixed) |
|||||
or sub-category |
N |
Mean (SD) |
N |
Mean (SD) |
|
95% CI |
|
% |
95% CI |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
01 Refractive IOLs |
|
|
|
|
|
|
|
|
|
|
|
|
Steinert et al., 199210 |
32 |
−7·67 (1·25) |
30 |
−8·19 (1·49) |
|
|
|
|
|
|
18·02 |
0·37 (−0·13, 0·88) |
Javitt, and Steinert, 20007 |
123 |
−8·40 (0·97) |
109 |
−8·46 (0·94) |
|
|
|
|
|
|
68·46 |
0·06 (−0·20, 0·32) |
|
|
|
|
|
|
|||||||
Leyland et al., 200215 |
45 |
0.05 (0·10) |
16 |
−0·01 (0·11) |
|
|
|
|
|
|
13·52 |
0·58 (−0·00, 1·16) |
Subtotal (95% CI) |
200 |
|
155 |
|
|
|
|
|
|
|
100·00 |
0·19 (−0.03, 0·40) |
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|||||
Test for heterogeneity: chi square = 3·17, df = 2 (P = 0·21) |
|
|
|
|
|
|
|
|
|
|||
Test for overall effect: Z = 1·73 (P = 0·08) |
|
|
|
|
|
|
|
|
|
|
||
02 Diffractive IOLs |
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal (95% CI) |
0 |
|
0 |
|
|
|
|
|
|
|
|
Not estimable |
Test for heterogeneity: not applicable |
|
|
|
|
|
|
|
|
|
|
||
Test for overall effect: not applicable |
|
|
|
|
|
|
|
|
|
|
||
Total (95% CI) |
200 |
|
155 |
|
|
|
|
|
|
|
100·00 |
−0·19 (−0.03, 0·40) |
|
|
|
|
|
|
|
|
|||||
Test for heterogeneity: chi square = 3·17, df = 2 (P = 0·21) |
|
|
|
|
|
|
|
|
|
|||
Test for overall effect: Z = 1·73 (P = 0·08) |
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
−10 |
−5 |
0 |
|
|
5 |
10 |
|
|
|
|
|
|
Favours multifocal |
Favours monofocal |
|
||||||
Figure 34.4 Distance visual acuity – mean best corrected
assumed to equal J3 from another. Despite these caveats, it is clear that unaided near acuity is improved by the use of multifocal IOLs. It is important to remember, however, that monofocal IOL near acuity can be restored by the use of reading glasses.
Question
Does the use of multifocal intraocular lenses offer benefits over monofocal intraocular lenses in terms of spectacle dependence?
263
Evidence-based Ophthalmology
Study |
Multifocal |
Monofocal |
|
|
|
|
|
|
OR (fixed) |
|
|
|
|
|
Weight |
OR (fixed) |
||||||||||||
or sub-category |
n/N |
n/N |
|
|
|
|
|
|
|
|
95% CI |
|
|
|
% |
95% CI |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
01 Refractive IOLs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percival and Setty, 19938 |
5/25 |
10/25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15·41 |
0·38 (0·11, 1·33) |
||
Javitt and Steinert 20007 |
4/123 |
37/109 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
73·10 |
0·07 (0·02, 0·19) |
||
Leyland et al., 200212 |
31/45 |
13/16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11·49 |
0·51 (0·13, 2·08) |
||
02 Diffractive IOLs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
El-Magrahby et al., 19926 |
3/23 |
7/24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5·27 |
0·36 (0·08, 1·63) |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Rossetti et al., 19949 |
5/38 |
25/42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18·24 |
0·10 (0·03, 0·32) |
||
Allen et al., 19965 |
14/116 |
92/101 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
76·49 |
0·01 (0·01, 0·03) |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0·1 |
0·2 |
0·5 |
1 |
2 |
5 |
10 |
|
|||||||||||||||||||
|
|
Favours multifocal |
|
|
|
Favours monofocal |
|
|||||||||||||||||||||
Figure 34.5 Near visual acuity – less than J3/J4 unaided
Table 34.2 Summary of subjective outcome (“patient satisfaction”) data
Study |
Validated measure? |
Outcome |
Multifocal |
Monofocal |
|
|
|
|
|
El-Maghraby et al., |
Not measured |
– |
– |
– |
19926 |
|
|
|
|
Steinert et al., 199210 |
No; standard |
Mean satisfaction |
1·77 (1·36) |
1·35 (0·80) |
|
questionnaire |
1–7 (1 = best, |
|
|
|
|
7 = worst) (SD) |
|
|
Percival and Setty, |
No; method not |
Percentage satisfied |
96% |
92% |
19938 |
reported |
|
|
|
Rossetti et al., 19949 |
No; method not |
Percentage satisfied |
68% |
78% |
|
reported |
or highly satisfied |
|
|
Allen et al., 19965 |
No; method not |
Overall visual |
95% |
93% |
|
reported |
satisfaction good |
|
|
Javitt and Steinart, |
Yes; TyPE |
Mean overall visual |
8·4 |
7·9 |
20007 |
questionnaire |
satisfaction 0–10 |
|
|
|
|
(0 = worst, 10 = best) |
|
|
Kamlesh et al., 200111 |
No; standard |
Percentage rating |
70% |
80% |
|
questionnaire |
vision as good |
|
|
Leyland et al., 200212 |
|
Median overall visual |
|
|
|
Yes; TyPE |
satisfaction 0–10 |
– |
– |
|
questionnaire |
(0 = worst; 10 = best) |
|
|
|
|
|
|
|
The evidence
In all RCTs the majority of multifocal IOL participants still used spectacles for some tasks – usually for reading small print. Freedom from spectacles was, however, more frequent with multifocal than monofocal IOLs in seven trials
(Peto odds ratio for spectacle dependence 0·15, 95% CI 0·11–0·22, Figure 34.6).
Comment
Spectacle independence is more likely to be achieved with use of the multifocal IOL than monofocal IOLs.
264
Multifocal and monofocal intraocular lenses
Study |
Multifocal |
Monofocal |
|
|
|
|
|
|
|
|
|
|
Peto OR |
|
|
|
|
|
Weight |
Peto OR |
|||||||||||
or sub-category |
n/N |
n/N |
|
|
|
|
|
|
|
|
|
|
|
95% CI |
|
|
|
% |
95% CI |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
01 Refractive IOLs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Steinert et al., 199210 |
22/31 |
25/28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7·77 |
0·33 (0·09, 1·16) |
||
Percival and Setty, 19938 |
14/25 |
23/25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7·87 |
0·16 (0·05, 0·56) |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Javitt and Steinert 20007 |
84/124 |
102/109 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30·07 |
0·20 (0·11, 0·38) |
||
Kamlesh et al., 200111 |
9/20 |
19/20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6·90 |
0·10 (0·03, 0·37) |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Leyland et al., 200212 |
32/45 |
16/16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6·45 |
0·18 (0·05, 0·73) |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Subtotal (95% CI) |
161/245 |
185/198 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
59·06 |
0·19 (0·12, 0·30) |
||
Test for heterogeneity: chi square = 1·78, df = 4 (P = 0·78) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Test for overall effect: Z = 7·13 (P < 0·00001) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
02 Diffractive IOLs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rossetti et al., 19949 |
20/38 |
39/42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12·54 |
0·13 (0·05, 0·35) |
||
Allen et al., 19965 |
72/116 |
97/98 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28·41 |
0·11 (0·06, 0·21) |
||
Subtotal (95% CI) |
92/154 |
136/140 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40·94 |
0·11 (0·07, 0·20) |
||
Test for heterogeneity: chi square = 0·07, df = 2 (P = 0·79) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Test for overall effect: Z = 7·73 (P < 0·00001) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total (95% CI) |
253/399 |
321/338 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100·00 |
0·15 (0·11, 0·22) |
||
Test for heterogeneity: chi square = 3·76, df = 6 (P = 0·71) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Test for overall effect: Z = 10·42 (P < 0·00001) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0·1 |
|
0·2 |
|
0·5 |
1 |
2 |
5 |
10 |
|
||||||||||||||||||||
|
|
Favours multifocal |
|
|
|
Favours monofocal |
|
||||||||||||||||||||||||
Figure 34.6 Spectacle dependence
However, in no trial did more than half of the participants achieve spectacle independence.
Question
Does the use of multifocal intraocular lenses offer benefits over monofocal intraocular lenses for in terms of depth of field?
The evidence
Four trials measured depth of field (the amount of defocus consistent with retention of useful acuity). Depth of field was improved with the multifocal IOL compared to the monofocal. One trial tested acuity with defocus from emmetropia, and reported the proportion achieving better than or equal to 6/12 acuity at each level of defocus. In the trial, 76% and 57% of multifocal and monofocal patients respectively achieved 6/12 with minus 1·25 D defocus, compared with 96% and 4% at minus 2·5 D defocus. Three trials measured the number of dioptres of defocus through which a 6/12 acuity was achieved, across a range of 3–6 dioptres plus or minus from emmetropia. The data were not presented in such a way as to be combined in a metaanalysis. However, each study reported increased depth of field with the multifocal IOL.
Question
Does the use of multifocal intraocular lenses offer benefits over monofocal intraocular lenses in terms of contrast sensitivity and glare?
The evidence
Contrast is the difference between the brightness of an image and its background divided by the total brightness of image plus background. Contrast sensitivity is the inverse of target contrast threshold. Six trials assessed contrast sensitivity (Table 34.3). All reported lower contrast sensitivity with the multifocal IOL, which is consistent with the expected optical effect of the lens.
Three trials objectively assessed glare using the Brightness Acuity Tester. The differences between lenses was not statistically significant. Seven trials reported subjective results and all describe an increased incidence of adverse visual phenomena with the multifocal IOL (Figure 34.7). In those trials that separated glare from haloes, the latter is the more frequently observed. The TyPE questionnaire quantifies the degree of bother from glare, haloes, and rings around lights on a scale of 0–4, where “not at all” scores 0, “a little bit” scores 1, “moderately” scores 2, “quite a bit” scores 3 and “extremely” scores 4. The mean scores (without glasses on) were 1·57 for the multifocal IOL and 0·43 for the monofocal.7 Median
265
Evidence-based Ophthalmology
Table 34.3 Contrast sensitivity (CS) results
Study |
Method |
Outcome |
Multifocal |
Monofocal |
|
|
|
|
|
El-Magrahby et al., 19926 |
Not tested |
– |
– |
– |
Steinert, 199210 |
Regan contrast acuity |
Acuity (lines read) at |
CS lower at all levels. |
Statistically |
|
charts |
96%, 50%, 25% and |
2.59 lines (SD 2.01) |
significant at 11% |
|
|
11% contrast |
at 11% |
4·37 lines (SD 2.05) |
Percival and Setty, |
Regan contrast acuity |
Acuity (lines read) at |
CS lower at all levels |
2·1 lines better |
19938 |
charts |
96%, 50%, 25% and |
(no analysis) |
acuity at 11% level |
|
|
11% contrast |
|
|
Rossetti et al., 19949 |
Pelli–Robson chart |
Mean score (log units) |
1·70 |
1·73 |
Allen et al., 19965 |
VCTS chart (6500 |
Mean of CS at 5 |
CS 57·9 to 83·9 lower |
CS 57·9 to 83·9 |
|
near, 6000 distance) |
spatial frequencies, at |
|
higher |
|
|
3 light levels (log units) |
|
|
Javitt and Steinert 20007 |
Not tested |
– |
– |
– |
Kamlesh et al., 200114 |
Pelli–Robson chart |
Mean CS score |
1·38 |
1·56 |
|
|
(log units) |
|
|
Leyland et al., 200212 |
Pelli–Robson chart |
Mean (SD) CS score |
1·66 (0·16) |
1·74 (0·15) |
|
|
(log units) |
|
|
|
|
|
|
|
scores of 1 (multifocal) and 0 (monofocal) were reported in the other study using the TyPE instrument.12
Comment
Contrast sensitivity was lower in participants with the multifocal IOL. The differences were smaller than would be expected, given the division of light between distance and near focus, which may result from post-receptoral visual processing. Whether the reduction in contrast sensitivity induced by the IOL would be clinically significant would depend on the contrast presented by the visual target and the contrast sensitivity of the patient’s retina. No significant differences between IOLs with respect to objective glare were reported. Subjective experience of adverse visual phenomena (glare/halo) was more likely with multifocal IOLS.
Question
Does the use of multifocal intraocular lenses offer benefits over monofocal intraocular lenses in terms of quality of life?
The evidence
The overall visual satisfaction results from the monofocal IOL control groups illustrate the high level of satisfaction with these
lenses. The non-validated multifocal subjective data are inconclusive. Using the TyPE instrument, one study found a small but statistically significant increase in overall visual satisfaction with the multifocal IOL7 (8·4/10 with the multifocal compared to 7·9/10 with the monofocal) and, as expected, a larger beneficial effect with respect to near vision (7·4/10 and 5·3/10). Another study found unaided overall visual satisfaction to be the same in the two IOL groups (median 8/10).12
Only El-Maghraby et al. (1992)6 did not report any subjective assessment. Of the other seven trials, only Javitt and Steinert (2000)7 and Leyland et al. (2002)12 used a validated instrument: the TyPE cataract questionnaire. The data could not be combined for meta-analysis, and are instead presented in Table 34.2.
Comment
Subjective outcomes are fundamental to the evaluation of multifocal IOLs but, like near vision, measurements were flawed in most of the trials. There was no consistent effect on visual satisfaction evident.
Adverse subjective visual phenomena, particularly haloes or rings around lights, were more prevalent and more troublesome in participants with the multifocal IOL. The lack of a consistent drop in patient satisfaction despite the prevalence of these phenomena could be interpreted as evidence that patients do not perceive them as severe.
266
|
|
|
|
|
|
Multifocal and monofocal intraocular lenses |
|||
Study |
Multifocal |
Monofocal |
|
Peto OR |
|
Weight |
Peto OR |
||
or sub-category |
n/N |
n/N |
|
95% CI |
|
% |
95% CI |
||
01 Refractive IOLs |
|
|
|
|
|
|
|
|
|
Percival and Setty, 19938 |
3/25 |
0/25 |
|
|
|
|
|
5·02 |
8·05 (0·80, 81·12) |
Kamlesh et al., 200111 |
12/20 |
7/20 |
|
|
|
|
|
17·86 |
2·66 (0·78, 9·05) |
Subtotal (95% CI) |
15/45 |
7/45 |
|
|
|
|
|
22·88 |
3·39 (1·15, 10·01) |
Test for heterogeneity: chi square = 0·69, df = 1 (P = 0·41) |
|
|
|
|
|
|
|
||
Test for overall effect: Z = 2·21 (P = 0·03) |
|
|
|
|
|
|
|
|
|
02 Diffractive IOLs |
|
|
|
|
|
|
|
|
|
Rossetti et al., 19949 |
29/38 |
13/42 |
|
|
|
|
|
35·17 |
6·03 (2·52, 14·43) |
Allen et al., 19965 |
21/79 |
9/70 |
|
|
|
|
|
41·95 |
2·33 (1·05, 5·19) |
Subtotal (95% CI) |
50/117 |
22/112 |
|
|
|
|
|
77·12 |
3·60 (2·00, 6·49) |
Test for heterogeneity: chi square = 2·47, df = 1 (P = 0·12) |
|
|
|
|
|
|
|
||
Test for overall effect: Z = 4·26 (P < 0·0001) |
|
|
|
|
|
|
|
|
|
Total (95% CI) |
65/162 |
29/157 |
|
|
|
|
|
100·00 |
3·55 (2·11, 5·96) |
Test for heterogeneity: chi square = 3·16, df = 3 (P = 0·37) |
|
|
|
|
|
|
|
||
Test for overall effect: Z = 4·79 (P < 0·00001) |
|
|
|
|
|
|
|
|
|
|
|
0·1 |
0·2 |
0·5 |
1 |
2 |
5 |
10 |
|
Favours multifocal |
Favours monofocal |
Figure 34.7 Glare/haloes
Discussion
Six of the eight included trials involved participants who had surgery on only one eye.5,6,8–12 Unilateral trials allow measurement of uniocular outcomes such as visual acuity, but are of limited use when attempting to measure the effect of the multifocal intraocular lenses on quality of life, especially where the fellow eye has good vision.
Implications for practice
There is good evidence that use of multifocal intraocular lenses improves near vision without any adverse effect on distance acuity. Spectacle independence is considerably more likely with use of these intraocular lenses when compared to the standard practice of monofocal implantation.
Whether the improvement in unaided near vision and increased incidence of spectacle independence are sufficiently high to outweigh the loss of contrast sensitivity and the experience of haloes is a matter for an individual patient to decide. The final choice for a patient is likely to depend on his or her motivation to be free of spectacles, guided by realistic expectations as to the likelihood of achieving this aim and understanding of the compromises involved.
Implications for research
The optical and visual effects of multifocal intraocular lenses are now well known. Future research on these and similar intraocular lenses should use validated subjective outcome criteria and strive for clarity in reporting of objective outcomes, particularly with regard to near vision. The search for alternative strategies to achieve spectacle independence such as monovision and accommodating intraocular lenses should continue.
References
1.Desai P, Reidy A, Minassian D. The National Cataract Surgery Survey 1997/98. A report of the results of the clinical outcomes. Br J Ophthalmol 1999;83:1336–40.
2.Minassian D, Rosen P, Dart J, Reidy A, Desai P, Sidhu M. Extracapsular cataract extraction compared with small incision surgery by phacoemulsification: a randomised trial. Br J Ophthalmol 2001;85(7): 822–9.
3.Javitt J, Wang F, Trentacost D, Rowe M, Tarantino N. Outcomes of cataract extraction with multifocal intraocular lens implantation.
Ophthalmology 1997;104:589–99.
4.Holladay J, van Dijk H, Lang A, Portney V, Willis T, Sun R, Oksman H. Optical performance of multifocal intraocular lenses. J Cataract Refract Surg 1990;16:413–22.
5.Allen E, Burton R, Webber S et al. Comparison of a diffractive bifocal and a monofocal intraocular lens. J Cataract Refract Surg 1996;22:446–51.
6.El-Maghraby A, Marzouky A, Gazayerli E et al. Multifocal versus
monofocal intraocular lenses. Visual and refractive comparisons.
J Cataract Refract Surg 1992;18:147–52.
267
Evidence-based Ophthalmology
7.Javitt JC, Steinert RF. Cataract extraction with multifocal intraocular lens implantation. A multinational clinical trial evaluating clinical, functional, and quality-of-life outcomes. Ophthalmology 2000;107: 2040–8.
8.Percival SP, Setty SS. Prospectively randomized trial comparing the pseudoaccommodation of the AMO ARRAY multifocal lens and a monofocal lens. J Cataract Refract Surg 1993;19:26–31.
9.Rossetti L, Carraro F, Rovati M, Orzalesi N. Performance of diffractive
multifocal intraocular lenses in extracapsular cataract surgery.
J Cataract Refract Surg 1994; 20:124–8.
10.Steinert RF, Post CT Jr, Brint SF et al. A prospective, randomized, double-masked comparison of a zonal-progressive multifocal
intraocular lens and a monofocal intraocular lens. Ophthalmology 1992;99:853–60.
11.Kamlesh M, Dadeya S, Kaushik S. Contrast sensitivity and depth of focus with aspheric multifocal versus conventional monofocal intraocular lens. Can J Ophthalmol 2001;36:197–201.
12.Leyland M, Langan L, Goolfee F, Lee N, Bloom P. Prospective randomised double-masked trial of bilateral multifocal, bifocal or monofocal intraocular lenses. Eye 2002;16:481–90.
13.Jadad AR, Moore RA, Carroll D. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1–12.
268
